Retrospective cohort study on the safety and efficacy of bevacizumab for metastatic colorectal cancer patients: The HGCSG0801study-Analysis of bevacizumab beyond progression (BBP).

被引：0
|
作者：
Fukushima, Hiraku
Yuki, Satoshi
Kobayashi, Yoshimitsu
Hatanaka, Kazuteru
Kusumi, Takaya
Hosokawa, Ayumu
Miyagishima, Takuto
Takeuchi, Satoshi
Kudo, Mineo
Komatsu, Yoshito
机构：
[1] Tomakomai City Hosp, Dept Gastroenterol, Tomakomai, Japan
[2] Hokkaido Univ, Sch Med, Dept Gastroenterol, Sapporo, Hokkaido, Japan
[3] Hakodate City Hosp, Dept Gastroenterol, Hakodate, Hokkaido, Japan
[4] Keiyukai Sapporo Hosp, Sapporo, Hokkaido, Japan
[5] Toyama Univ, Toyama, Japan
[6] Kushiro Rosai Hosp, Dept Internal Med, Kushiro, Japan
[7] Hokkaido Univ Hosp, Dept Med Oncol, Sapporo, Hokkaido, Japan
[8] Sapporo Hokuyu Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan
[9] Hokkaido Univ Hosp, Dept Canc Ctr, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.684
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
684
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Retrospective Cohort Study on the Safety and Efficacy of Bevacizumab with Chemotherapy for Metastatic Colorectal Cancer Patients: The HGCSG0801 Study
    Sogabe, Susumu
    Komatsu, Yoshito
    Yuki, Satoshi
    Kusumi, Takaya
    Hatanaka, Kazuteru
    Nakamura, Michio
    Kato, Takashi
    Miyagishima, Takuto
    Hosokawa, Ayumu
    Iwanaga, Ichiro
    Sakata, Yuh
    Asaka, Masahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (04) : 490 - 497
  • [2] Retrospective cohort study on the safety and efficacy of bevacizumab for metastatic colorectal cancer patients: The HGCSG0801 study-Efficacy of KRAS mutational status.
    Sogabe, Susumu
    Yuki, Satoshi
    Hayashi, Hideyuki
    Naruse, Hirohito
    Nakamura, Michio
    Iwanaga, Ichiro
    Kato, Takashi
    Takagi, Tomofumi
    Okuda, Hiroyuki
    Komatsu, Yoshito
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] An observational cohort study of bevacizumab and chemotherapy in metastatic colorectal cancer patients: safety and efficacy with analysis by age group
    Esther Tahover
    Ayala Hubert
    Mark Temper
    Azzam Salah
    Tamar Peretz
    Tamar Hamburger
    Beatrice Uziely
    Targeted Oncology, 2015, 10 : 55 - 63
  • [4] An observational cohort study of bevacizumab and chemotherapy in metastatic colorectal cancer patients: safety and efficacy with analysis by age group
    Tahover, Esther
    Hubert, Ayala
    Temper, Mark
    Salah, Azzam
    Peretz, Tamar
    Hamburger, Tamar
    Uziely, Beatrice
    TARGETED ONCOLOGY, 2015, 10 (01) : 55 - 63
  • [5] Survival Outcomes With Use of Bevacizumab Beyond Progression (BBP) in Metastatic Colorectal Cancer (MCRC) Patients (Pts)
    Cartwright, T.
    Yu, E.
    Yim, Y.
    Hartnett, H.
    Chung, H.
    Halm, M.
    Forsyth, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S437 - S437
  • [6] HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of first-line treatment
    Ito, K.
    Yuki, S.
    Nakano, S.
    Yagisawa, M.
    Sawada, K.
    Ishiguro, A.
    Muto, O.
    Hatanaka, K.
    Okuda, H.
    Sato, A.
    Sasaki, Y.
    Nakamura, M.
    Sasaki, T.
    Kobayashi, T.
    Dazai, M.
    Nakatsumi, H.
    Ueda, A.
    Tateyama, M.
    Sogabe, S.
    Matsumoto, R.
    Sakata, Y.
    Komatsu, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S108 - S108
  • [7] Updated analysis: A retrospective cohort study evaluating the safety and efficacy of regorafenib in patients with metastatic colorectal cancer-HGCSG1401.
    Ota, Yumiko
    Yuki, Satoshi
    Liarada, Kazuaki
    Yoshida, Shuntaro
    Tsuji, Yasushi
    Kobayashi, Yoshimitsu
    Hatanaka, Kazuteru
    Okuda, Hiroyuki
    Sasaki, Takahide
    Dazai, Masayoshi
    Konno, Jun
    Ohta, Tomoyuki
    Honda, Takuya
    Ishiguro, Atsushi
    Muto, Osamu
    Sato, Yasushi
    Kato, Sosuke
    Onodera, Kei
    Sakata, Yuh
    Komatsu, Yoshito
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [8] HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of second-line treatment
    Kaneko, S.
    Ito, K.
    Yuki, S.
    Harada, K.
    Yagisawa, M.
    Sawada, K.
    Ishiguro, A.
    Muto, O.
    Hatanaka, K.
    Okuda, H.
    Sato, A.
    Sasaki, Y.
    Nakamura, M.
    Sasaki, T.
    Tsuji, Y.
    Ando, T.
    Kato, K.
    Wakabayashi, T.
    Kotaka, M.
    Takahashi, Y.
    Sakata, Y.
    Komatsu, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S125 - S125
  • [9] Retrospective cohort study on the safety and efficacy of panitumumab for patients with metastatic colorectal cancer: The HGCSG1002 study-Analysis of adverse events
    Dazai, Masayoshi
    Fukushima, Hiraku
    Sato, Yasushi
    Yuki, Satoshi
    Ohnuma, Hiroyuki
    Okuda, Hiroyuki
    Tsuji, Yasushi
    Kawamoto, Yasuyuki
    Hatanaka, Kazuteru
    Iwanaga, Ichiro
    Koike, Masahiko
    Kato, Takashi
    Nakamura, Michio
    Sogabe, Susumu
    Fujikawa, Koshi
    Hosokawa, Ayumu
    Hisai, Hiroyuki
    Tateyama, Miki
    Sakata, Yuh
    Komatsu, Yoshito
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [10] A retrospective cohort study evaluating the safety and efficacy of regorafenib in patients with metastatic colorectal cancer; The HGCSG1401 study - first report
    Dazai, M.
    Yuki, S.
    Muranaka, T.
    Yoshida, S.
    Ohta, Y.
    Hatanaka, K.
    Tsuji, Y.
    Ohta, T.
    Sato, A.
    Eto, K.
    Onodera, K.
    Sato, Y.
    Kato, K.
    Nakamura, M.
    Muto, O.
    Ishiguro, A.
    Tateyama, M.
    Okuda, H.
    Sakata, Y.
    Komatsu, Y.
    ANNALS OF ONCOLOGY, 2015, 26 : 48 - 48
12345